33 employees
Ayala Pharmaceuticals a clinical-stage biopharmaceutical company focused on developing and commercializing small molecule therapeutics.
2017
$30M
from 1 investors over 1 rounds
Ayala Pharmaceuticals raised $30M on May 28, 2019
Investors: aMoon Fund